234 related articles for article (PubMed ID: 34702779)
21. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.
Singh A; Gupta A; Collins BL; Qamar A; Monda KL; Biery D; Lopez JAG; de Ferranti SD; Plutzky J; Cannon CP; Januzzi JL; Di Carli MF; Nasir K; Bhatt DL; Blankstein R
J Am Coll Cardiol; 2019 May; 73(19):2439-2450. PubMed ID: 31097165
[TBL] [Abstract][Full Text] [Related]
22. Influence of the LDL-Receptor Genotype on Statin Response in Heterozygous Familial Hypercholesterolemia: Insights From the Canadian FH Registry.
Roy G; Couture P; Genest J; Ruel I; Baass A; Bergeron J; Brisson D; Brunham LR; Cermakova L; Gaudet D; Khoury E; Laflamme N; Kennedy BA; Hegele RA; Drouin-Chartier JP
Can J Cardiol; 2022 Mar; 38(3):311-319. PubMed ID: 34774719
[TBL] [Abstract][Full Text] [Related]
23. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.
Foody JM; Toth PP; Tomassini JE; Sajjan S; Ramey DR; Neff D; Tershakovec AM; Hu H; Tunceli K
Vasc Health Risk Manag; 2013; 9():719-27. PubMed ID: 24265554
[TBL] [Abstract][Full Text] [Related]
24. LDL-cholesterol change and goal attainment following statin intensity titration among Asians in primary care: a retrospective cohort study.
Fang HSA; Gao Q; Lee ML; Hsu W; Tan NC
Lipids Health Dis; 2021 Jan; 20(1):2. PubMed ID: 33407522
[TBL] [Abstract][Full Text] [Related]
25. Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia.
Khine H; Yuet WC; Adams-Huet B; Ahmad Z
Am Heart J; 2016 Sep; 179():1-9. PubMed ID: 27595674
[TBL] [Abstract][Full Text] [Related]
26. Use of Lipid-modifying Therapy and LDL-C Goal Attainment in a High-Cardiovascular-Risk Population in the Netherlands.
Kuiper JG; Sanchez RJ; Houben E; Heintjes EM; Penning-van Beest FJA; Khan I; van Riemsdijk M; Herings RMC
Clin Ther; 2017 Apr; 39(4):819-827.e1. PubMed ID: 28347514
[TBL] [Abstract][Full Text] [Related]
27. LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia.
Bogsrud MP; Græsdal A; Johansen D; Langslet G; Hovland A; Arnesen KE; Mundal LJ; Retterstøl K; Wium C; Holven KB
J Clin Lipidol; 2019; 13(2):279-286. PubMed ID: 30910667
[TBL] [Abstract][Full Text] [Related]
28. Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry.
Amrock SM; Duell PB; Knickelbine T; Martin SS; O'Brien EC; Watson KE; Mitri J; Kindt I; Shrader P; Baum SJ; Hemphill LC; Ahmed CD; Andersen RL; Kullo IJ; McCann D; Larry JA; Murray MF; Fishberg R; Guyton JR; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Underberg JA; Thompson P; Duffy D; Linton MF; Shapiro MD; Moriarty PM; Knowles JW; Ahmad ZS
Atherosclerosis; 2017 Dec; 267():19-26. PubMed ID: 29080546
[TBL] [Abstract][Full Text] [Related]
29. Management of High and Very High-Risk Subjects with Familial Hypercholesterolemia: Results from an Observational Study in Bulgaria.
Petrov IS; Postadzhiyan AS; Tokmakova MP; Kitova LG; Tsonev SN; Addison J; Petkova RT; Lachev VI
Folia Med (Plovdiv); 2018 Sep; 60(3):389-396. PubMed ID: 30355848
[TBL] [Abstract][Full Text] [Related]
30. LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C.
van Delden XM; Huijgen R; Wolmarans KH; Brice BC; Barron JK; Blom DJ; Marais AD
Atherosclerosis; 2018 Oct; 277():327-333. PubMed ID: 30270067
[TBL] [Abstract][Full Text] [Related]
31. Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe.
Ruel I; Aljenedil S; Sadri I; de Varennes É; Hegele RA; Couture P; Bergeron J; Wanneh E; Baass A; Dufour R; Gaudet D; Brisson D; Brunham LR; Francis GA; Cermakova L; Brophy JM; Ryomoto A; Mancini GBJ; Genest J
Clin Chem; 2018 Feb; 64(2):355-362. PubMed ID: 29038147
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of severe familial hypercholesterolemia in patients presenting for cardiac catheterization.
Zafrir B; Shapira C; Lavie G; Halon DA; Flugelman MY
J Clin Lipidol; 2016; 10(6):1338-1343. PubMed ID: 27919350
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
35. Clinical Management of High and Very High Risk Patients with Hyperlipidaemia in Central and Eastern Europe: An Observational Study.
Petrov I; Dumitrescu A; Snejdrlova M; Zafrir B; Wożakowska-Kapłon B; Fabryova L; Pintarić H; Bridges I; Petkova R
Adv Ther; 2019 Mar; 36(3):608-620. PubMed ID: 30758746
[TBL] [Abstract][Full Text] [Related]
36. Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins.
Fox KM; Tai MH; Kostev K; Hatz M; Qian Y; Laufs U
Clin Res Cardiol; 2018 May; 107(5):380-388. PubMed ID: 29273856
[TBL] [Abstract][Full Text] [Related]
37. Efficiency and problems of statin therapy in patients with heterozygous familial hypercholesterolemia.
Korneva V; Kuznetsova T; Julius U
Atheroscler Suppl; 2019 Dec; 40():79-87. PubMed ID: 31818452
[TBL] [Abstract][Full Text] [Related]
38. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
39. Attainment of Low-Density Lipoprotein Cholesterol Targets and Prescribing Pattern of Lipid-Lowering Medications among Patients with Familial Hypercholesterolemia Attending Specialist Clinics.
Chua YA; Nazli SA; Rosman A; Kasim SS; Ibrahim KS; Md Radzi AB; Mohd Kasim NA; Nawawi H
J Atheroscler Thromb; 2023 Oct; 30(10):1317-1326. PubMed ID: 36567112
[TBL] [Abstract][Full Text] [Related]
40. Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia.
Pisciotta L; Sallo R; Rabacchi C; Wunsch A; Calandra S; Bertolini S
Nutr Metab Cardiovasc Dis; 2012 Oct; 22(10):831-5. PubMed ID: 21920719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
